Corporate Headquarters
Vector Laboratories, Inc.
6737 Mowry Ave
Newark, CA 94560
United States
Associates with IL27 to form the IL-27 interleukin, a heterodimeric cytokine which functions in innate immunity. IL-27 has pro- and anti-inflammatory properties, that can regulate T-helper cell development, suppress T-cell proliferation, stimulate cytotoxic T-cell activity, induce isotype switching in B-cells, and that has diverse effects on innate immune cells. Among its target cells are CD4 T-helper cells which can differentiate in type 1 effector cells (TH1), type 2 effector cells (TH2) and IL17 producing helper T-cells (TH17). It drives rapid clonal expansion of naive but not memory CD4 T-cells. It also strongly synergizes with IL-12 to trigger interferon-gamma/IFN-gamma production of naive CD4 T-cells, binds to the cytokine receptor WSX-1/TCCR. Another important role of IL-27 is its antitumor activity as well as its antiangiogenic activity with activation of production of antiangiogenic chemokines.
Gene Name: | Epstein-Barr virus induced 3 |
Synonyms: | EBI3, Epstein-Barr virus induced 3, IL-27 subunit beta, IL27 subunit, IL27B, Interleukin-27 subunit beta, IL-27B, Cytokine receptor, EBV-induced gene 3 protein, IL35 subunit |
Target Sequences: | NM_005755 NP_005746.2 Q14213 |
If you do not find the reagent or information you require, please contact Customer.Support@LSBio.com to inquire about additional products in development.